Parental Leave Does Not Impact Residents’ Subsequent Board Scores
WEDNESDAY, July 27, 2022 (HealthDay News) -- Taking extended leave during residency for parental or medical leave does not appear to impact subsequent board scores, according to a study published in the July issue of the American Journal of Physical Medicine & Rehabilitation.
James T. McDeavitt, M.D., from Baylor College of Medicine in Houston, and colleagues assessed differences in part I (written) and part II (oral) certification examination performance and determined the prevalence of delays in taking board examinations among physical medicine and rehabilitation residents who took and did not take an extended leave of absence during residency.
The researchers identified four reasons for extended leave of absence: medical; parental; academic/remediation; and unspecified personal reasons. Compared with those without leave, residents who took an extended leave of absence for medical or parental reasons had similar or better odds of passing their part I and part II examinations. However, residents who took leave for academic/remediation concerns or unspecified personal reasons had lower odds of passing their board examinations. Examination delays associated with parental or personal health leaves did not affect board pass rates.
"If you have residents going out on parental leave, the data would show that’s OK," McDeavitt said in a statement. "You should not be overly concerned about the performance of those residents when they come back."
Related Posts
Depression in Pregnancy Tied to Behavior Issues in Kids
THURSDAY, June 2, 2022 (HealthDay News) -- Children whose mothers had rising...
Gout Medicine May Also Help Fight Heart Failure
MONDAY, May 23, 2022 (HealthDay News) -- The anti-inflammatory benefits of a...
Incluso sin síntomas, las personas con ómicron son mucho más propensas a propagar la COVID, según estudios
LUNES, 10 de enero de 2022 (HealthDay News) -- Unos investigadores señalan que...
Pfizer: según los datos finales, la pastilla para la COVID sigue siendo fuerte contra la enfermedad grave
MARTES, 14 de diciembre de 2021 (HealthDay News) -- Pfizer Inc. anunció el...